Drug Interactions between capmatinib and Prilosec
This report displays the potential drug interactions for the following 2 drugs:
- capmatinib
- Prilosec (omeprazole)
Interactions between your drugs
omeprazole capmatinib
Applies to: Prilosec (omeprazole) and capmatinib
Coadministration of capmatinib with a proton pump inhibitor may decrease the plasma concentrations and anti-tumor activity of capmatinib. Concomitant use of rabeprazole decreased capmatinib systemic exposure (AUC0-INF) and peak plasma concentration (Cmax) by 25% and 38%, respectively. The mechanism of the interaction is unknown. Caution and monitoring are advised if capmatinib is administered along with a proton pump inhibitor.
References (1)
- (2020) "Product Information. Tabrecta (capmatinib)." Novartis Pharmaceuticals
Drug and food interactions
No alcohol/food interactions were found. However, this does not necessarily mean no interactions exist. Always consult your healthcare provider.
Therapeutic duplication warnings
No warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
See also
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Check Interactions
To view an interaction report containing 4 (or more) medications, please sign in or create an account.
Save Interactions List
Sign in to your account to save this drug interaction list.